Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
about
The structure of a purple acid phosphatase involved in plant growth and pathogen defence exhibits a novel immunoglobulin-like foldLidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in miceFactor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.Pharmacokinetics of C-1027 in mice as determined by TCA-RA method.Engineered production of cancer targeting peptide (CTP)-containing C-1027 in Streptomyces globisporus and biological evaluationSite-specific PEGylation of lidamycin and its antitumor activity.Characterization of the SgcF epoxide hydrolase supporting an (R)-vicinal diol intermediate for enediyne antitumor antibiotic C-1027 biosynthesis.Total synthesis and related studies of large, strained, and bioactive natural productsA Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.Chemiluminescent detection of cell apoptosis enzyme by gold nanoparticle-based resonance energy transfer assay.Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM.Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.DBD-Hunter: a knowledge-based method for the prediction of DNA-protein interactions.A novel enediyne-integrated antibody-drug conjugate shows promising anti-tumor efficacy against CD30+ lymphomas.
P2860
Q27684866-0AFB76A8-E561-42CD-A5CB-254193A20AC5Q33477869-2E606575-B691-4998-B5BF-46DEA0B46021Q34287997-3E48D389-BD25-4C85-9F6D-23F25CC00736Q34605450-EEDE52AE-CC01-4605-8D49-DC1B17275446Q35994054-8B06200A-F3D1-45E5-B76E-DDDFEFF4CBD1Q36237972-EDFB2AE9-D323-4708-B83E-BC0E954360ADQ37440402-FE033082-1B6A-475B-AD32-BEF84BF493E3Q37592828-3100A19B-A59D-43CE-9D3D-95F0F81D29AFQ38917149-B411121E-D155-4A59-B7C6-91C0D3F05C3EQ38962248-7F2FFFCD-F1A6-48FC-A353-93418FAB5C64Q39028715-F5296673-533C-470A-B584-20CAEC76DDB1Q39685735-5A467D0E-3565-48C7-95DE-AF0CD4BD3972Q39704501-424A0D3D-6840-4856-A662-4A17A0F1F954Q39989439-362EE391-84C6-4D70-B5B8-1B5A5C1DBDB5Q40640989-1AB50F69-5AB0-4FE6-968D-A1C5A5118E82Q47217500-8A2392E9-E144-4213-9B1C-7BFE0E685C6D
P2860
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@ast
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@en
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@nl
type
label
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@ast
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@en
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@nl
prefLabel
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@ast
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@en
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@nl
P2093
P356
P1476
Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore
@en
P2093
S Fukuda-Ishisaka
P304
P356
10.1006/JMBI.2001.4621
P407
P577
2001-05-25T00:00:00Z